Antidiabetes drugs - DiabetesontheNet

Rosiglitazone withdrawn: PCDS response

Developing a local practice guideline for SMBG in non-insulin treated type 2 diabetes

Cardiovascular risk: Managing hypertension in type 2 diabetes

PCDS Newsletter: Report from the 70th Scientific Sessions of the American Diabetes Association

Insulin options in type 2 diabetes following market discontinuation of Mixtard® 30

Diabetes: The lifelong journey

New SIGN guidance on the management of diabetes

The point of good injection technique

Oral antidiabetes drugs: A retrospective analysis of risk

Sodium glucose co-transporter-2 inhibitors: A novel drug class

Analysing adherence: Controlling prescribing costs

Working together to improve adherence

Diabetes: The need to take control

Tailored use of GLP-1 receptor agonists in type 2 diabetes

Putting newer therapies into practice

NICE additions to the type 2 guideline

Thumbs-up for NICE guidelines

New therapies guidelines: NICE versus ADA/EASD